Neogen Chemicals Ltd (NEOGEN) is currently trading at 2,176.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Neogen Chemicals is an Indian specialty chemicals manufacturer producing bromine‑based compounds, organo‑lithium products, and battery materials via its subsidiary Neogen Ionics, with custom synthesis, contract manufacturing, and recently expanded electrolyte and salt production capacities aimed at battery supply chains and pharma/agro specialty markets. Q1 FY27 showed strong operational recovery and strategic inflection: consolidated revenue of INR 250 crore (up 34% YoY), EBITDA of INR 48 crore (up 53% YoY) and margin expansion to 19.3%, driven by organo‑lithium, inorganic chemicals and initial battery chemicals sales, including highest ever quarterly revenue in organo‑lithium and battery portfolios. Battery vertical is scaling rapidly: Neogen Ionics reported INR 19 crore revenue in Q1 FY27 versus INR 5 crore a year ago, gained provisional approvals from four international customers, secured Japanese technology and Morita’s USD20 million equity commitment, and targets commercial electrolyte and salt ramp through H2 FY27 and FY28. Balance sheet and funding actions are material: reconstruction of Dahej near completion, cumulative insurance recoveries of INR 164 crore received with INR 186 crore net receivable pending, and the Board approved an INR 600 crore QIP to deleverage and fund future battery and organo‑lithium opportunities. Management expects structural multi‑year growth: battery materials capacity is designed to address 30–40 GWh equivalent demand with potential revenues of INR 2,400–2,900 crore by FY29, positioning battery chemicals to become roughly half of revenues within five years while the legacy specialty chemical business optimises product mix and margins.

Over the past 52 weeks, Neogen Chemicals Ltd has traded between a low of ₹978.00 and a high of ₹2,785.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Neogen Chemicals Ltd has a market capitalization of approximately 6,539.94. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Neogen Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 183.91 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 6,539.94 Cr, Neogen Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Neogen Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Neogen Chemicals Ltd is 183.91. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Neogen Chemicals raised ₹599.9998 crore (₹5,99,99,98,015) by allotting shares to qualified institutional buyers.

Neogen Chemicals fixed the QIP floor price at ₹2,189.73 per equity share.

Neogen Chemicals has fixed the QIP floor price at ₹2,189.73 per equity share.

Standalone revenue from operations was ₹252.28 crore and standalone net profit was ₹19.44 crore for the quarter ended June 30, 2026.